Epidemiological bridging by injection drug use drives an early HIV epidemic.

The risk of acquiring sexually transmitted infections (STIs) depends on individual behavior and the network of risky partnerships in which an individual participates. STI epidemics often spread rapidly and primarily among individuals central to transmission networks; and thus they often defy the mass-action principle since incidence is not proportional to the infectious fraction of the population. Here, we estimate the contact network structure for an Atlanta, Georgia community with heterogeneous sexual and drug-related risk behaviors and build a detailed transmission model for HIV through this population. We show that accurate estimation of epidemic incidence requires careful measurement and inclusion of diverse factors including concurrency (having multiple partners), the duration of partnerships, serosorting (preference for partners with matching disease state), and heterogeneity in the number and kinds of partners. In the focal population, we find that injection drug users (IDUs) do not directly cause many secondary infections; yet they bridge the heterosexual and men-who-have-sex-with-men (MSM) populations and are thereby indirectly responsible for extensive transmission.

[1]  S. Blower,et al.  Sex acts, sex partners, and sex budgets: implications for risk factor analysis and estimation of HIV transmission probabilities. , 1993, Journal of acquired immune deficiency syndromes.

[2]  J. Baeten,et al.  Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. , 2003, Current HIV research.

[3]  Tim Brown,et al.  Potential impact of HIV among IDUs on heterosexual transmission in Asian settings: scenarios from the Asian Epidemic Model , 2003 .

[4]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[5]  C. Latkin,et al.  A Bridge Over Troubled Waters: Factors Associated With Non-Injection Drug Users Having Injection Drug-using Sex Partners , 2006, Journal of acquired immune deficiency syndromes.

[6]  A. Levy,et al.  Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. , 2008, The Journal of infectious diseases.

[7]  R. Mikolajczyk,et al.  Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases , 2008, PLoS medicine.

[8]  M E J Newman,et al.  Predicting epidemics on directed contact networks. , 2006, Journal of theoretical biology.

[9]  Elizabeth Pisani,et al.  Sexual Behavior Among Injection Drug Users in 3 Indonesian Cities Carries a High Potential for HIV Spread to Noninjectors , 2003, Journal of acquired immune deficiency syndromes.

[10]  Tanja Popovic,et al.  HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006. , 2009, MMWR. Morbidity and mortality weekly report.

[11]  B. Leynaert,et al.  Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV. , 1998, American journal of epidemiology.

[12]  M. Prins,et al.  Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study , 2006, AIDS.

[13]  M. Keeling,et al.  Modeling Infectious Diseases in Humans and Animals , 2007 .

[14]  J. Hopcroft,et al.  Are randomly grown graphs really random? , 2001, Physical review. E, Statistical, nonlinear, and soft matter physics.

[15]  R. Pastor-Satorras,et al.  Generation of uncorrelated random scale-free networks. , 2004, Physical review. E, Statistical, nonlinear, and soft matter physics.

[16]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[17]  C. Hicks,et al.  Does antiretroviral therapy prevent HIV transmission to sexual partners? , 2007, Current HIV/AIDS reports.

[18]  S. Goodreau,et al.  HIV serosorting as a harm reduction strategy: evidence from Seattle, Washington , 2009, AIDS.

[19]  Leonard M. Freeman,et al.  A set of measures of centrality based upon betweenness , 1977 .

[20]  Richard G. White,et al.  Quantifying HIV-1 transmission due to contaminated injections , 2007, Proceedings of the National Academy of Sciences.

[21]  Davey M. Smith,et al.  Serosorting can potentially increase HIV transmissions , 2007, AIDS.

[22]  M. Kretzschmar,et al.  New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users , 2008, AIDS.

[23]  M. H. Hansen,et al.  On the Theory of Sampling from Finite Populations , 1943 .

[24]  P. Bacchetti,et al.  Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis , 2001, The Lancet.

[25]  C. Mahé,et al.  HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? , 2002, AIDS.

[26]  John J. Potterat,et al.  The Atlanta Urban Networks Study: a blueprint for endemic transmission , 2000, AIDS.

[27]  Erik M. Volz,et al.  Probability based estimation theory for respondent driven sampling , 2008 .

[28]  Bruce A. Reed,et al.  The Size of the Giant Component of a Random Graph with a Given Degree Sequence , 1998, Combinatorics, Probability and Computing.

[29]  M. Newman,et al.  Applying Network Theory to Epidemics: Control Measures for Mycoplasma pneumoniae Outbreaks , 2003, Emerging infectious diseases.

[30]  Nicholas C. Grassly,et al.  Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission in the Russian Federation, China and India , 2003 .

[31]  M. Newman,et al.  Random graphs with arbitrary degree distributions and their applications. , 2000, Physical review. E, Statistical, nonlinear, and soft matter physics.

[32]  N. Christakis,et al.  The Spread of Obesity in a Large Social Network Over 32 Years , 2007, The New England journal of medicine.

[33]  P. Vanhems,et al.  Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. , 2000, The Journal of infectious diseases.

[34]  Matthew J. Salganik,et al.  5. Sampling and Estimation in Hidden Populations Using Respondent-Driven Sampling , 2004 .

[35]  L. Meyers,et al.  Epidemic thresholds in dynamic contact networks , 2009, Journal of The Royal Society Interface.

[36]  Edward H. Kaplan,et al.  Let the Needles Do the Talking! Evaluating the New Haven Needle Exchange , 1993 .

[37]  L. Meyers,et al.  Susceptible–infected–recovered epidemics in dynamic contact networks , 2007, Proceedings of the Royal Society B: Biological Sciences.

[38]  M. Kretzschmar,et al.  Can HIV epidemics among IDUs ‘trigger’ a generalised epidemic? , 2003 .

[39]  Erik M Volz,et al.  Using Respondent-Driven Sampling in a Hidden Population at Risk of HIV Infection: Who Do HIV-Positive Recruiters Recruit? , 2009, Sexually transmitted diseases.